BiotechTube
Home/Mariana Oncology/Bill Diamantopoulos, PharmD
BD

Bill Diamantopoulos, PharmD

Chief Technology Officer

Mariana Oncology

Therapeutic Areas

Oncology

Mariana Oncology Pipeline

DrugIndicationPhase
DLL3-Targeted RLTDLL3-expressing cancers (e.g., small cell lung cancer, neuroendocrine cancers)Preclinical
B7-H3-Targeted RLTB7-H3-expressing solid tumorsPreclinical

Leadership Team at Mariana Oncology

FZ
Fred Zecri, PhD
Chief Scientific Officer – Site Head
TT
Travis Tirrell, MS, JD
Chief Operating Officer and General Counsel
CB
Caroline Breitbach, PhD
SVP, Asset & Portfolio Leadership
MV
Melissa Vasbinder, PhD
Head of Research
View full Mariana Oncology profile